Autolus Therapeutics (AUTL) Assets Average (2017 - 2025)

Autolus Therapeutics (AUTL) has reported Assets Average for 9 consecutive years, with $625.5 million the latest figure, recorded in Q4 2025.

• Quarterly Assets Average fell 22.31% year-over-year to $625.5 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $625.5 million (down 22.31% YoY) and the FY2025 annual result came in at $685.9 million, up 18.45% from the prior year.
• Assets Average eased to $625.5 million in Q4 2025 per AUTL's latest filing, from $691.5 million in the prior quarter.
• Over the last five years, Assets Average for AUTL reached as high as $877.5 million in Q2 2024 and fell as low as $288.9 million in Q3 2022.
• A 5-year average of $522.2 million and a median of $442.0 million in 2023 frame the typical range for Assets Average.
• Annual changes were most pronounced in 2024 — Assets Average jumped 106.05% — and 2025, when it decreased 22.31%.
• Year by year, Assets Average stood at $351.1 million in 2021, then rose by 7.39% to $377.1 million in 2022, then rose by 3.63% to $390.7 million in 2023, then jumped by 106.05% to $805.1 million in 2024, then fell by 22.31% to $625.5 million in 2025.
• According to Business Quant data, Assets Average over the past three periods registered $625.5 million, $691.5 million, and $733.7 million for Q4 2025, Q3 2025, and Q2 2025 respectively.